Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew P Cheng

Showing results (151-160 of 156) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 156 results.
CMAJ Open|October 6, 2022
Cost-effectiveness of remdesivir plus usual care versus usual care alone for hospitalized patients with COVID-19: an economic evaluation as part of the Canadian Treatments for COVID-19 (CATCO) randomized clinical trialVincent I Lau, Robert Fowler, Ruxandra Pinto, et al.
Critical Care (London, England)|February 28, 2024
Using a targeted metabolomics approach to explore differences in ARDS associated with COVID-19 compared to ARDS caused by H1N1 influenza and bacterial pneumoniaChel Hee Lee, Mohammad M Banoei, Mariam Ansari, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2023
Early Oral Antibiotic Switch in Staphylococcus aureus Bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch ProtocolDana de Kretser, Jocelyn Mora, Max Bloomfield, et al.
CMAJ Open|March 10, 2021
Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort studySrinivas Murthy, Patrick M Archambault, Anika Atique, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 20, 2022
Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trialKarim Ali, Tanweer Azher, Mahin Baqi, et al.
The New England Journal of Medicine|June 17, 2026
Cefazolin for Methicillin-Susceptible <i>Staphylococcus aureus</i> Bacteremia, Todd C Lee, Lauren A Barina, et al.
Pageof 16

Showing results (151-160 of 156) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 156 results.
CMAJ Open|October 6, 2022
Cost-effectiveness of remdesivir plus usual care versus usual care alone for hospitalized patients with COVID-19: an economic evaluation as part of the Canadian Treatments for COVID-19 (CATCO) randomized clinical trialVincent I Lau, Robert Fowler, Ruxandra Pinto, et al.
Critical Care (London, England)|February 28, 2024
Using a targeted metabolomics approach to explore differences in ARDS associated with COVID-19 compared to ARDS caused by H1N1 influenza and bacterial pneumoniaChel Hee Lee, Mohammad M Banoei, Mariam Ansari, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2023
Early Oral Antibiotic Switch in Staphylococcus aureus Bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch ProtocolDana de Kretser, Jocelyn Mora, Max Bloomfield, et al.
CMAJ Open|March 10, 2021
Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort studySrinivas Murthy, Patrick M Archambault, Anika Atique, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 20, 2022
Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trialKarim Ali, Tanweer Azher, Mahin Baqi, et al.
The New England Journal of Medicine|June 17, 2026
Cefazolin for Methicillin-Susceptible <i>Staphylococcus aureus</i> Bacteremia, Todd C Lee, Lauren A Barina, et al.
Pageof 16